Cargando…
Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection
BACKGROUND AND AIMS: Studies evaluating the impact of SARS-CoV-2 on chronic liver disease (CLD) are limited and have focused mostly on hospitalized patients or those with cirrhosis. We aim to evaluate the impact of underlying CLD on patient outcomes following COVID-19 using a one of the largest COVI...
Autores principales: | Wong, Robert J., Zhang, Yi, Thamer, Mae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894759/ https://www.ncbi.nlm.nih.gov/pubmed/36777086 http://dx.doi.org/10.1016/j.jceh.2023.01.014 |
Ejemplares similares
-
SARS-CoV-2 infection in patients with underlying chronic liver disease is associated with significantly greater risks of inpatient hospitalization, intensive care unit admission, and overall mortality
por: Wong, Robert, et al.
Publicado: (2022) -
Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study
por: Ge, Jin, et al.
Publicado: (2021) -
Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes
por: Molina, Israel, et al.
Publicado: (2021) -
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients
por: Romano, Ciro, et al.
Publicado: (2023) -
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
por: Ge, Jin, et al.
Publicado: (2021)